Jeeva operates as a company providing software solutions. The company offers a range of services including electronic data capture, patient engagement portals, and protocol design and writing. It aims to improve the efficiency and effectiveness of clinical trials. It primarily serves the biopharmaceutical industry, research investigators, and patient groups. It was founded in 2019 and is based in Manassas, Virginia.
Jeeva's Product Videos
Jeeva's Products & Differentiators
Jeeva eClinical Platform
Single login per clinical trial for sites, sponsors, CROs, to collaboratively manage flexible clinical research operations for patient education, screening, patient recruitment on the Internet, remote eConsent, electronic patient reported outcomes, clinical outcomes assessments, telemedicine or video conferencing for remote follow up visits, lab report and adverse event management. Fully decentralized or hybrid clinical trial operations to ensure continuity and integrity of clinical studies during uncertain times such as the pandemic.
Expert Collections containing Jeeva
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Jeeva is included in 3 Expert Collections, including Artificial Intelligence.
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Latest Jeeva News
Feb 14, 2024
Posted on The pharmaceutical industry stands out as a hub of innovation, attracting investors seeking standout companies. Redwood Scientific Technologies Inc. (OTC: RSCI), headquartered in New York, has been pioneering groundbreaking work in this sector. On February 6, 2023, the company unveiled a significant development: an agreement with Jeeva Clinical Trials. Under the terms of the agreement, the two firms would work together on initiating a clinical efficacy examination of Redwood Scientific Technologies’ TBX-Free oral strip offerings designed to aid in quitting smoking and e-cigarette usage. Furthermore, it was highlighted that Redwood had enlisted the expertise of George Mason University, a leading academic institution in the United States, to oversee the effectiveness evaluation of its novel product. Jason Cardiff, the CEO of the organization, addressed the recent advancements, emphasizing Redwood Scientific Technologies’ dedication to crafting safe and efficient solutions to aid countless individuals in breaking free from nicotine dependency. Cardiff expressed confidence that partnering with esteemed institutions would facilitate this goal. He underscored the company’s acknowledgment of the burgeoning crisis, affirming management’s commitment to expeditiously introducing the product to market. In this context, it’s crucial to recognize nicotine as one of the most addictive substances globally, functioning as both a sedative and a stimulant. According to reports, over 8 million adults in the United States utilize e-cigarettes, with over 28.3 million smoking traditional cigarettes. Even more concerning is the revelation that over 16.5% of high school students engage in tobacco use. Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website. Media Contact
Jeeva Frequently Asked Questions (FAQ)
When was Jeeva founded?
Jeeva was founded in 2019.
Where is Jeeva's headquarters?
Jeeva's headquarters is located at 10432 Balls Ford Road, Manassas.
What is Jeeva's latest funding round?
Jeeva's latest funding round is Grant.
How much did Jeeva raise?
Jeeva raised a total of $150K.
Who are the investors of Jeeva?
Investors of Jeeva include Virginia Innovation Partnership and Virginia Venture Partners.
Who are Jeeva's competitors?
Competitors of Jeeva include Medidata and 4 more.
What products does Jeeva offer?
Jeeva's products include Jeeva eClinical Platform and 4 more.
Who are Jeeva's customers?
Customers of Jeeva include George Mason University, University of California, San Francisco, 21st century dads foundation and IndoUSrare.
Compare Jeeva to Competitors
Medable operates as a global platform for decentralized clinical trials. It solves the systemic challenges inherent in modern clinical trials including access, interoperability between systems, and inefficient technology experiences. Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.
Castor is a medical research data platform. It provides decentralized clinical trial solutions to control clinical trial design. It analyzes, manages, and organizes medical data collected from multiple electronic records. The company was founded in 2012 and is based in New York, New York.
Medrio provides electronic data capture software for the process of clinical research. The platform supports phase I-IV trials, outcomes research, registries, retrospective chart reviews, and other clinical study needs. It was founded in 2005 and is based in San Francisco, California.
Bloqcube develops cloud-based software enabling distributed and remote clinical trials with storage and real-time reporting of clinical data. It focuses on accelerating clinical trials using modern technology and built integrated clinical trials management and finance systems that enable life science companies to automate trials, monitor in real-time, and deliver immutable data, and more. The company was founded in 2017 and is based in Piscataway, New Jersey.
ObvioHealth develops ClaimIt, a proprietary digital platform that utilizes online and mobile app interfaces to execute clinical trials. ClaimIt removes the costly overhead of physical site visits and brings the trial directly to the mobile device of each subject. It was founded in 2015 and is based in New York, New York.
Curebase provides decentralized clinical research software solutions. It reduces recruitment times, automates manual steps, and lets drug companies distribute their trials to clinics. It was founded in 2017 and is based in San Francisco, California.